Navigation Links
Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
Date:1/15/2014

LAWRENCEVILLE, N.J., Jan. 15, 2014 /PRNewswire/ -- Celsion Corporation (the "Company") (NASDAQ: CLSN) today announced that it has received commitments from institutional investors to purchase an aggregate of approximately $15 million of the Company's common stock in an at-the-market registered direct offering, led by a dedicated health care fund.

The Company entered into definitive purchase agreements with these investors pursuant to which the Company agreed to sell an aggregate of 3,603,603 shares of its common stock at a per share price of $4.1625.  Additionally, for each share of common stock purchased, investors will receive a Series A Warrant to purchase one-quarter of a share of our common stock at an exercise price of $4.10 per share, which shall be exercisable immediately and expire five years from the date of issuance, and a Series B Warrant to purchase one-quarter of a share of our common stock at an exercise price of $4.10 per share, which shall be exercisable immediately and expire one year from the date of issuance. The closing of the offering is expected to take place on or about January 21, 2014, subject to the satisfaction of customary closing conditions.

The estimated net proceeds to the Company from the offering are expected to be approximately $13.8 million.  With the net proceeds from this offering, the Company projects to have an unaudited cash and investment balance of approximately $57 million.  The Company intends to use the net proceeds from this offering for general corporate purposes.

H.C. Wainwright & Co., LLC  acted as exclusive placement agent in connection with the offering.

A shelf registration statement (File No. 333-183286) relating to the shares issued in the offering has been filed with and declared effective by the Securities and Exchange Commission (the "SEC"
'/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
2. Celsion Corporation Announces Strategic Loan Facility
3. Celsion Corporation Reports Third Quarter 2013 Financial Results and Provides Business Update
4. Celsion Corporation to Hold Third Quarter 2013 Financial Results Conference Call on Tuesday, November 12, 2013
5. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
6. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
7. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
8. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
9. Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
10. Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013
11. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the ... $125 million aggregate principal amount of 3.75% Convertible Senior ... and sold only to qualified institutional buyers pursuant to ... amended (the "Securities Act"). The Notes bear ... payable semiannually in arrears on June 15 and December ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, ... (CTMC), and Integrated Clinical Trial Services, LLC (ICTS), ... for clinical trials announce that they have formed ... Services (i-CTMS). i-CTMS will provide a broad range ... biotechnology and medical device companies. i-CTMS ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... COLUMBUS, Ohio, Jan. 8 IntelligentMDx a developer and ... that verification studies of the IntelligentMDx BK Viral ... the Limit of Detection, linearity, specificity and reproducibility ... were determined. The data obtain agreed with internally ...
... have identified mutations in a gene that predict a high ... Although the researchers caution that further research is needed to ... or IKAROS, lead to leukemia relapse, the findings ... to assess the risk of treatment failure. By using a ...
Cached Medicine Technology:Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 2Verification Studies of IntelligentMDx's Proprietary Molecular Diagnostic Assay Process Have Been Completed 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6
(Date:12/17/2014)... Nwe is the co-author of a new weight loss book ... the Ace Medical Weight Loss Center in Rock Hill, SC. ... the industry of weight loss, and how several fad diets ... television shows, however, she says the topic of obesity is ... basic laughs, which she believes impacts whether Americans view it ...
(Date:12/17/2014)... 17, 2014 HeartMath® Inc., recognized ... stress, heart rate variability (HRV), heart coherence and ... extensive HRV databases and algorithms to chipset manufacturers ... enable HeartMath’s partners to offer its HRV solutions, ... as well as its normative HRV databases and ...
(Date:12/17/2014)... No matter how far modern medicine advances, ... head louse parasite—a common childhood malady and a source ... six and twelve million individuals will suffer an infestation. ... company comes to the rescue, providing an all-natural treatment ... track record of customer service, and effectiveness in getting ...
(Date:12/17/2014)... -- As gas prices rose in recent years, so ... In times of gas increases, more people start ... the researchers explained. They examined data gathered between ... number of motorcycle registrations in the United States and ... analysis revealed a strong association between rising gas prices ...
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Poor students get more fruits ... new study finds. But, the opposite is true for ... fruits and vegetables at school may give a healthy boost ... no matter what the family income level, students all ate ... study found. The study was published recently in the ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... TUESDAY, April 10 (HealthDay News) -- Although research has suggested ... to an increased risk of death in heart-failure patients compared ... the case. "Use of this and other similar drugs ... with heart failure," said Dr. Gregg Fonarow, co-director of the ...
... Barrett, MD will represent Kessler Foundation,s Stroke Rehabilitation Research ... at the Ernest N. Morial Convention Center in New ... abstracts will be presented representing the Laboratory,s collaborative investigation ... stroke. Spatial neglect is a hidden disability of functional ...
... health concern in low- and middle-income countries, and there ... contribution to help tackle the disease, states an analysis ... Cancer kills more people than HIV/AIDS, tuberculosis and malaria ... a projected rise through 2030 of 82% in low- ...
... By Denise Mann HealthDay Reporter , ... urinary incontinence, the available treatments may cause more problems ... because of side effects that can include dry mouth ... is marked by frequent, sudden urges to urinate that ...
... registration is now open online for TCT 2012 ... the Cardiovascular Research Foundation. Every year, TCT ... leading medical researchers and clinicians from around the ... research developments in interventional cardiovascular medicine. Now in ...
... , MONDAY, April 9 (HealthDay News) -- Even small ... illnesses such as diabetes, heart failure and lung disease ... a new study indicates. Researchers from the Harvard ... related to climate change could claim thousands of lives ...
Cached Medicine News:Health News:Common Blood Pressure Drug Safe for Heart Failure: Study 2Health News:Common Blood Pressure Drug Safe for Heart Failure: Study 3Health News:NJ stroke researchers report advances in spatial neglect research at AAN Conference 2Health News:Urinary Incontinence Drugs May Be More Trouble Than They're Worth 2Health News:Climate Change Could Be Tough on Seniors' Health: Study 2
... VISION is Guidant's first cobalt chromium stent ... MINI VISION to have remarkably thin struts ... creating a highly deliverable stent. Less metal, ... outcomes in small vessel treatment. The Guidant ...
... IRIS Medical IQ 810 infrared diode ... retinal disorders and glaucoma. The Companys ... technological innovation and is designed to ... (MIP) procedures in the office and ...
... early is best corrected with GP lenses. ... be present, GP lenses will help the ... will neutralize the distortions of the corneal ... is a fitting challenge for even the ...
... "a quantum leap forward in the evolution of ... Rose K lens has become the world's most ... keratoconus.,Unlike traditional contact lenses, the complex geometry built ... the cone like shape of the cornea, for ...
Medicine Products: